Prix De L'Action
27.72
Variation Quotidienne
-0.30 -1.07%
Mensuellement
-2.26%
Annuel
16.57%
Q1 Prévisions
27.46




Capital Ordinaire Changement Date
AstraZeneca USD 1.55B 206K 2025-12
Biogen USD 146.7M 200K 2025-09
Genmab DKK 10M 56M 2025-03
Gilead Sciences USD 1.24B 1000K 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
GRIFOLS EUR 680.58M 846K 2025-12
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12
Incyte USD 198.46M 2.33M 2025-12
Merck EUR 434.78M 0 2025-12
Neurocrine Biosciences USD 100.1M 400K 2025-12
Novartis USD 1.94B 23.4M 2025-06
Roche Holding CHF 795.62M 699.54K 2025-12
UCB EUR 584M 0 2024-12
Vertex Pharmaceuticals USD 254M 0 2025-12